Prior culture with concanavalin A increases intramuscular migration of transplanted myoblast
Hijiri Ito MD,
Patricia L. Hallauer PhD,
Kenneth E.M. Hastings PhD,
Jacques P. Tremblay PhD,
Hijiri Ito MD
Département d'Anatomie and Laboratoire de Neurobiologie, Université Laval, Hôpital de l'Enfant-Jésus, Québec (Qc), Canada
Search for more papers by this authorPatricia L. Hallauer PhD
Montreal Neurological Institute, McGill University, Montreal (Qc), Canada
Search for more papers by this authorKenneth E.M. Hastings PhD
Montreal Neurological Institute, McGill University, Montreal (Qc), Canada
Search for more papers by this authorCorresponding Author
Jacques P. Tremblay PhD
Département d'Anatomie and Laboratoire de Neurobiologie, Université Laval, Hôpital de l'Enfant-Jésus, Québec (Qc), Canada
Département d'Anatomie and Laboratoire de Neurobiologie, Université Laval, Hôpital de l'Enfant-Jésus, Québec (Qc), CanadaSearch for more papers by this authorHijiri Ito MD,
Patricia L. Hallauer PhD,
Kenneth E.M. Hastings PhD,
Jacques P. Tremblay PhD,
Hijiri Ito MD
Département d'Anatomie and Laboratoire de Neurobiologie, Université Laval, Hôpital de l'Enfant-Jésus, Québec (Qc), Canada
Search for more papers by this authorPatricia L. Hallauer PhD
Montreal Neurological Institute, McGill University, Montreal (Qc), Canada
Search for more papers by this authorKenneth E.M. Hastings PhD
Montreal Neurological Institute, McGill University, Montreal (Qc), Canada
Search for more papers by this authorCorresponding Author
Jacques P. Tremblay PhD
Département d'Anatomie and Laboratoire de Neurobiologie, Université Laval, Hôpital de l'Enfant-Jésus, Québec (Qc), Canada
Département d'Anatomie and Laboratoire de Neurobiologie, Université Laval, Hôpital de l'Enfant-Jésus, Québec (Qc), CanadaSearch for more papers by this authorFirst published: 07 December 1998
Citations: 38
Abstract
The effect was studied of pretreatment with concanavalin A (ConA) of primary myoblast cultures on their migration when transplanted into muscles. As donors, transgenic CD1 mice in which the β-galactosidase gene is under the control of a CMV promoter (CMVLacZ.9) were used. The myoblasts were grown with 20 μg/mL ConA during the 2 days before injecting them in the right tibialis anterior (TA) muscles of BALB/c mice and mdx mice. As a control, myoblasts from the same primary cultures were grown without ConA and injected in the left TA muscles. The host muscles were not previously irradiated or damaged by notexin injection. The recipient mice were immunosuppressed with FK506. Four days after myoblast transplantation, the area occupied by donor cells was significantly greater (more than threefold) following culture with ConA than without ConA. This result indicates that culture of myoblasts with ConA permits them to migrate farther following their transplantation in host muscles not previously damaged by notexin injection or irradiation. This suggests that pretreatment with ConA may be helpful for myoblast transplantation in humans. The mechanism of this effect still remains to be investigated. © 1998 John Wiley & Sons, Inc. Muscle Nerve 21:291–297, 1998.
References
- 1 Arahata K, Ishiura S, Ishiguro T, Tsukahara T, Suhara Y Eguchi C, Ishihara T, Nonaka I, Ozawa E, Sugita H: Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 1988; 333: 861–863.
- 2 Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, Dimauro S, Kunkel LM, Hoffman EP, Rowland LP: Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 1988; 54: 447–452.
- 3 Carnwath JW, Shotton DM: Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci 1987; 80: 39–54.
- 4 Carpenter S, Karpati G, Zubrzycka-Gaarn E, Bulman DE, Ray PN, Worton RG: Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electronmicroscopic cytochemical study. Muscle Nerve 1990; 13: 376–380.
- 5 Chen M, Li HJ, Fang Q, Goodwin TG, Florendo JA, Law PK: Dystrophin cytochemistry in mdx mouse muscles injected with labeled normal myoblasts. Cell Transplant 1992; 1: 17–22.
- 6 Dayer JM, Russell RGG, Krane SM: Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor. Science 1977; 195: 181–183.
- 7 Dennis JW, Laferte' S, Waghorne C, Breitman ML, Kerbel RS: b1-6 branching of Asn-linked oligo saccharides is directly associated with metastasis. Science 1987; 236: 582–585.
- 8 Dennis JC, Waller CA, Schirrmacher V: Identification of asparagine-linked oligosaccharides involved in tumor cell adhesion to laminin and type IV collagen. J Cell Biol 1984; 99: 1416–1423.
- 9
Fan Y,
Maley M,
Beilharz M,
Grounds M:
Rapid death of injected myoblasts in myoblast transfer therapy.
Muscle Nerve
1996;
19:
853–860.
10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8 CAS PubMed Web of Science® Google Scholar
- 10 Gussoni E, Pavlath GK, Lanctot AM, Sharma KR, Miller RG Steinman L, Blau HM: Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992; 356: 435–438.
- 11 Hoffman EP, Brown RH, Kunkel LM: Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919–928.
- 12 Hoffman EP, Hudecki MS, Rosenberg PA, Polleira CM Kunkel LM: Cell and fiber type distribution of dystrophin. Neuron 1988; 1: 411–420.
- 13 Hoffman EP, Kundson CM, Campbell KP, Kunkel LM: Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature 1987; 330: 745–748.
- 14 Huard J, Bouchard JP, Roy R, Maloulin F, Dansereau G, Labrecque C, Albert N, Richards CL, Lemieux B, Tremblay JP: Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 1992; 15: 550–560.
- 15 Hurum S, Sodek J, Aubin JE: Synthesis of collagen, collagenase and collagenase inhibitors by cloned human gingival fibroblasts and the effect of concanavalin A. Biochem Biophys Res Commun 1982; 107: 357–366.
- 16 Karpati G, Ajdukovic D, Arnold D, Glendhill RB, Guttmann R Holland P, Koch PA, Shoubridge E, Spence D, Vanasse M Watters GV, Abrahamowicz M, Duff C, Worton RG: Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 1993; 34: 8–17.
- 17 Karpati G, Pouliot Y, Zubrzycka-Gaarn E, Carpenter S, Ray PN, Worton RG, Holland P: Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol 1989; 135: 27–32.
- 18 Kinoshita I, Huard J, Tremblay JP: Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Muscle Nerve 1994; 17: 975–980.
- 19 Kinoshita I, Vilquin JT, Gue'rette B, Asselin I, Roy R, Tremblay JP: Very efficient myoblast allotransplantation in mice under FK 506 immunosuppression. Muscle Nerve 1994; 17: 1407–1415.
- 20 Kinoshita I, Vilquin JT, Roy R, Tremblay JP: Successive injections in mdx mice of myoblasts grown with bFGF. Neuromusc Disord 1996; 6: 187–193.
- 21 Kinoshita I, Vilquin JT, Tremblay JP: Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve 1995; 18: 834–841.
- 22 Labrecque C, Roy R, Tremblay JP: Immune reaction after myoblast transplantation in mouse muscle. Transplant Proc 1992; 24: 2889–2892.
- 23 Law PK, Bertorini TE, Goodwin TG, Chen M, Fang Q, Li HJ Kirby DS, Florendo JA, Herrod HG, Golden GS: Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 1990; 336: 114–115.
- 24 Law PK, Goodwin TG, Fang Q, Deering MB, Duggirala V Larkin C, Florendo JA, Li HJ, Chen M, Cormett J, Li LM Shirzad A, Quinley T, Yoo TJ, Holcomb R: Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Cell Transplant 1993; 2: 485–505.
- 25 Law P, Goodwin T, Fang Q, Deering M, Duggirala V, Larkin C, Florendo A, Quinley T, Cornett J, Shirzad A, Yoo T, Holcomb R: Whole body myoblast transfer. Transplant Proc 1994; 26: 3381–3383.
- 26 Law PK, Goodwin TG, Li HJ: Histoincompatible myoblast injection improves muscle structure and function of dystrophic mice. Transplant Proc 1988; 20: 1114–1119.
- 27 Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, Nagaraja H Stephens R, Lantry L, Morris GE, Burghes AHM: Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 1995; 333: 832–838.
- 28 Morgan JE, Moore SE, Walsh FS, Partridge TA: Formation of skeletal muscle in vivo from the mouse C2 cell line. J Cell Sci 1992; 102: 779–787.
- 29 Morgan JE, Pagel CN, Sherratt T, Partridge TA: Long-term persistence and migration of myogenic cells injected into preirradiated muscles of mdx mice. J Neurol Sci 1993; 115: 191–200.
- 30 Morgan JE, Watt DJ, Sloper JC, Partridge TA: Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells. J Neurol Sci 1988; 86: 137–147.
- 31 Overall CM, Sodek J: Concanavalin A produces a matrixdegradative phenotype in human fibroblasts. J Biol Chem 1990; 265: 21141–21151.
- 32 Partridge TA: Myoblast transfer: a possible therapy for inherited myopathies? Muscle Nerve 1991; 14: 197–212.
- 33 Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM: Conversion of mdx myofibres from dystrophin-negative to positive by injection of normal myoblasts. Nature 1989; 337: 176–179.
- 34 Rando TA, Blau HM: Primary mouse myoblast purification characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 1994; 125: 1275–1287.
- 35 Saklatvala J, Dingle JT: Identification of catabolin, a protein from synovium which induces degradation of cartilage in organ culture. Biochem Biophys Res Commun 1980; 96: 1225–1231.
- 36 Salviati G, Betto R, Geoldo S, Bonilla E, Miranda AF, Dimauro S: Cell fractionation studies indicate that dystrophin is a protein of surface membrane of skeletal muscle. Biochem J 1989; 258: 837–841.
- 37 Sharon N, Liz H: Lectins as cell recognition molecules. Science 1989; 246: 227–234.
- 38 Sharon N, Liz H: Lectins: cell-agglutinating and sugar-specific proteins. Science 1972; 177: 949–959.
- 39 Sugita H, Arahata K, Ishiguro T, Suhara Y, Tsukahara T, Ishiura S, Eguchi C, Nonaka I, Ozawa E: Negative immunostaining of Duchenne muscular dystrophy (DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA. Proc Jpn Acad 1988; 64: 37–39.
- 40 Tremblay JP, Bouchard JP, Malouin F, The'au D, Cottrell F Collin H, Rouche A, Gilgenkrants S, Abbadi N, Tremblay M Tome' FMS, Fardeau M: Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromusc Disord 1993; 3: 583–592.
- 41 Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL: Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993; 2: 99–112.
- 42 Vassalli JD, Hamilton J, Reich E: Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate. Cell 1977; 11: 695–705.
- 43 Wahl LM, Wahl SM, Mergenhagen SE, Martin GR: Collagenase production by lymphokine-activated macrophages. Science 1975; 187: 261–263.
- 44 Wakeford S, Watt DJ, Partridge TA: X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 1991; 14: 42–50.
- 45 Wang HM, Hurum S, Sodek J: ConA stimulation of collagenase synthesis by human gingival fibroblasts. J Periodontal Res 1983; 18: 149–155.
- 46 Watt DJ, Karasinski J, England MA: Migration of LacZ positive cells from the tibialis anterior to the extensor digitorum longus muscle of the X-linked muscular dystrophic (mdx) mouse. J Muscle Res Cell Motil 1993; 14: 121–132.
- 47 Watt DJ, Karasinski J, Moss J, England MA: Migration of muscle cells. Nature 1994; 368: 406–407.
- 48 Yogeeswaran G, Salk PL: Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 1981; 212: 1514–1516.
- 49 Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AHM Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG: The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 1988; 333: 466–469.
Citing Literature
